An EY report open to a page titled 'INDIA PRIVATE CREDIT: H1 2026 REVIEW' in an office.
India’s private credit market demonstrated robust activity in the healthcare sector during the first half of 2026, with an estimated $3.5 billion deployed across more than 100 deals. This figure marks a slight increase from the $3.4 billion deployed in the latter half of 2025, indicating sustained investor interest in the segment.
A report by EY highlighted that domestic funds played a dominant role in these transactions, underscoring the growing capacity and confidence of local financial institutions in providing capital for healthcare businesses. While the report did not specify the exact breakdown of domestic versus international fund participation, the emphasis on local players suggests a maturing domestic private credit landscape.
Healthcare has emerged as the second-largest sector for private credit deals in India during this period. This positions the sector as a key area for alternative financing, reflecting its resilience and growth potential, particularly in a market with increasing demand for healthcare services and infrastructure.
The EY report’s findings suggest that private credit is becoming an increasingly vital source of funding for Indian healthcare companies, potentially supporting expansion, innovation, and operational enhancements within the industry. The consistent deployment of capital indicates a stable and evolving market for private credit providers and borrowers alike.
About the Author
